ResearcherID - CLICK HERE Scientific Journal Impact Factor (SJIF-2020) - CLICK HERE

SUITABILITY OF INTRAVENOUS MAGNESIUM SULPHATE IN SEVERE ASTHMA BASED ON ITS ENDPOINT

Dr. Yousaf Raza, Dr. Saima Hassan, Dr. Muhammad Hasnain

Objective: Continued enthusiasm for intravenous magnesium sulfate to use it in many different signs other than controlling eclamptic attacks has led analysts to try it as the smooth muscle relaxant in patients of severe bronchial asthma. The outcomes were mostly debatable, subsequently researchers led the current investigation to decide the suitability of intravenous magnesium sulphate in severe asthma founded on its endpoint. Methods: Our current research was conducted at BVH Bahawalpur from October 2018 to September 2019. We thoughtfully checked all cases of severe asthma conceded during the review period on the treatment charts and extracted important data. Each of the patients was first treated with standard asthma therapy and then given 4ml of 53% (2g) MgSO4 weakened MgSO4 in 260ml of typical saline solution intravenously. The results were displayed in rate and frequency while the calm age was displayed as ± SD on average. Results: The average age of people was 46.30 ± 21.2 years. Authors had the woman power in the sample population (62.4%). Patients who were effectively relieved were 34.4% while those who were no longer active were 58.6%. There was no significant gender distinction in result (p > 0.06). Conclusion: Researchers originate that intravenous magnesium sulfate was ineffective in counselling cases through severe asthma with respect to improving endurance levels. Keywords: Magnesium sulphate; Bronchial asthma; Effectiveness; Emergency administration.